Advisor Group Holdings, Inc. Sage Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 231 shares of SAGE stock, worth $1,323. This represents 0.0% of its overall portfolio holdings.

Number of Shares

231

Previous 667 65.37%

Holding current value

$1,323

Previous $7,000 85.71%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$7.02 - $13.08 $3,060 - $5,702	-436 Reduced 65.37%	231 $1,000
Q2 2024 Aug 13, 2024	SELL	$10.58 - $17.9 $60,464 - $102,298	-5,715 Reduced 89.55%	667 $7,000
Q1 2024 May 10, 2024	BUY	$18.62 - $26.95 $5,176 - $7,492	278 Added 4.55%	6,382 $119,000
Q4 2023 Feb 12, 2024	SELL	$17.1 - $22.26 $103,027 - $134,116	-6,025 Reduced 49.67%	6,104 $132,000
Q3 2023 Nov 13, 2023	BUY	$16.75 - $48.98 $38,340 - $112,115	2,289 Added 23.26%	12,129 $249,000
Q2 2023 Aug 10, 2023	SELL	$40.65 - $59.54 $143,088 - $209,580	-3,520 Reduced 26.35%	9,840 $462,000
Q1 2023 May 12, 2023	SELL	$37.27 - $46.57 $17,256 - $21,561	-463 Reduced 3.35%	13,360 $560,000
Q4 2022 Feb 10, 2023	BUY	$32.2 - $43.61 $4,830 - $6,541	150 Added 1.1%	13,823 $527,000
Q3 2022 Nov 14, 2022	SELL	$32.28 - $43.27 $4,551 - $6,101	-141 Reduced 1.02%	13,673 $536,000
Q2 2022 Aug 10, 2022	BUY	$27.52 - $37.99 $66,268 - $91,479	2,408 Added 21.11%	13,814 $447,000
Q1 2022 May 04, 2022	BUY	$30.71 - $45.71 $272,581 - $405,721	8,876 Added 350.83%	11,406 $378,000
Q3 2021 Nov 05, 2021	SELL	$40.26 - $57.37 $268,977 - $383,288	-6,681 Reduced 72.53%	2,530 $111,000
Q2 2021 Aug 02, 2021	BUY	$54.88 - $79.29 $452,430 - $653,666	8,244 Added 852.53%	9,211 $527,000
Q1 2021 May 13, 2021	SELL	$70.65 - $96.76 $12,293 - $16,836	-174 Reduced 15.25%	967 $73,000
Q4 2020 Feb 10, 2021	BUY	$58.41 - $89.06 $36,506 - $55,662	625 Added 121.12%	1,141 $99,000
Q3 2020 Nov 12, 2020	SELL	$41.13 - $62.45 $11,598 - $17,610	-282 Reduced 35.34%	516 $31,000
Q2 2020 Aug 14, 2020	SELL	$25.95 - $43.15 $2,465 - $4,099	-95 Reduced 10.64%	798 $32,000
Q1 2020 May 18, 2020	BUY	$26.15 - $77.24 $23,351 - $68,975	893 New	893 $25,000

Others Institutions Holding SAGE

# of Institutions

218

Shares Held

46.4M

Call Options Held

847K

Put Options Held

188K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $340M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Sage Therapeutics, Inc. Transaction History